Steven Holtzman, Biogen Idec on why Pharma investors should focus more on product than return

Uploaded by jray on February 18, 2014 at 4:08 pm

Established drug manufacturer Biogen Idec’s Executive VP of Corporate Development’s Steven Holtzman discusses the pessimism surrounding the possibility of cr…

Rating:
Views:861 views
Tags: Biogen, Focus, Holtzman, Idec, investors, More, Pharma, Product, return, should, Steven, than
Categories: mitochondria

Comments

Write a comment Cancel reply

This is a widget area - If you go to "Appearance" in your WP-Admin you can change the content of this box in "Widgets", or you can remove this box completely under "Theme Options"

Cure Autism

Help us. We're trapped. And we're smart!

Steven Holtzman, Biogen Idec on why Pharma investors should focus more on product than return

Comments

Write a comment Cancel reply